2.Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma: experience in Korea cancer hospital.
Soo Yong LEE ; Dae Geun JEON ; Sung Soo KIM ; Ja June JANG ; Kyung Ja CHO
Journal of Korean Medical Science 1993;8(2):121-126
During the last decade, many clinical investigators at various cancer centers have reported the efficacy of various chemotherapeutic agents in the treatment of osteosarcoma. The regimens using high-dose methotrexate (HDMTX) with citrovorum factor rescue are now considered to be one of the most effective treatments of choice. From December 1989 to May 1991, sixteen patients with Enneking's stage (Enneking et al., 1980) IIB osteosarcoma of the extremities were treated with a high-dose methotrexate regimen. After two cycles of preoperative chemotherapy, an operation was performed; either limb salvage or amputation. The resected lesions were examined pathologically and classified according to Huvos' criteria. On pathological examination, 8 (50%) cases showed Grade IV; 1 (6.25%) Grade III; 4 (25%) Grade II; and 3 (18.75%) Grade I. The types of surgery performed were tumor prosthesis replacement (11); wide resection with or without reconstruction (2); resection and arthrodesis (1); and amputation (2).
Adolescent
;
Adult
;
Bone Neoplasms/*drug therapy/pathology/surgery
;
Child
;
Combined Modality Therapy
;
Female
;
Humans
;
Male
;
Methotrexate/administration & dosage/*therapeutic use
;
Osteosarcoma/*drug therapy/pathology/surgery
3.Clinicopathologic diagnosis of de-differentiated chondrosarcoma.
Jin HUANG ; Hui-zhen ZHANG ; Li ZHENG ; Juan ZHOU ; Zhi-ming JIANG
Chinese Journal of Pathology 2009;38(12):820-823
OBJECTIVETo study the clinicopathologic and radiologic features of dedifferentiated chondrosarcoma, focusing on its diagnosis and differential diagnosis.
METHODClinical, radiological and pathologic findings of 14 cases of dedifferentiated chondrosarcoma (including biopsy and surgical specimens) were analyzed by hematoxylin and eosin stained sections and immunohistochemistry.
RESULTSThe mean age of patients was 52 years. The male-to-female ratio was 9:5. The most common sites of involvement were pelvis, femur and humerus, similar to the conventional chondrosarcoma. Radiologically, they were malignant tumors with dimorphic pattern. Grossly, central chondrosarcomas were more common than those of the peripheral. An essential histological feature of dedifferentiated chondrosarcoma was an abrupt interface between the low-grade cartilaginous tumor and high-grade anaplastic sarcoma. The most common dedifferentiated components were osteosarcoma, malignant fibrous histocytoma and fibrosarcoma. False negative diagnosis and erroneous diagnosis were frequent when only one-time biopsy was available.
CONCLUSIONSDedifferentiated chondrosarcoma is a rare subtype of chondrosarcoma with poor prognosis, which has different features of clinical manifestation, imaging features and pathological characteristics, compared to conventional chondrosarcoma and chondroblastic osteosarcoma.
Adult ; Aged ; Bone Neoplasms ; diagnostic imaging ; drug therapy ; pathology ; surgery ; Cell Differentiation ; Chondrosarcoma ; diagnostic imaging ; drug therapy ; pathology ; surgery ; Chondrosarcoma, Mesenchymal ; pathology ; Diagnosis, Differential ; Female ; Femoral Neoplasms ; diagnostic imaging ; drug therapy ; pathology ; surgery ; Follow-Up Studies ; Humans ; Humerus ; pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Osteosarcoma ; pathology ; Pelvic Bones ; pathology ; Radiography ; Vimentin ; metabolism ; Young Adult
4.Skeletal metastasis: treatments, mouse models, and the Wnt signaling.
Kenneth C VALKENBURG ; Matthew R STEENSMA ; Bart O WILLIAMS ; Zhendong ZHONG
Chinese Journal of Cancer 2013;32(7):380-396
Skeletal metastases result in significant morbidity and mortality. This is particularly true of cancers with a strong predilection for the bone, such as breast, prostate, and lung cancers. There is currently no reliable cure for skeletal metastasis, and palliative therapy options are limited. The Wnt signaling pathway has been found to play an integral role in the process of skeletal metastasis and may be an important clinical target. Several experimental models of skeletal metastasis have been used to find new biomarkers and test new treatments. In this review, we discuss pathologic process of bone metastasis, the roles of the Wnt signaling, and the available experimental models and treatments.
Animals
;
Bone Neoplasms
;
drug therapy
;
metabolism
;
radiotherapy
;
secondary
;
surgery
;
Breast Neoplasms
;
metabolism
;
pathology
;
Disease Models, Animal
;
Drug Delivery Systems
;
Female
;
Humans
;
Lung Neoplasms
;
metabolism
;
pathology
;
Male
;
Mice
;
Prostatic Neoplasms
;
metabolism
;
pathology
;
Wnt Proteins
;
metabolism
;
Wnt Signaling Pathway
;
beta Catenin
;
metabolism
5.Development of Acute Megakaryoblastic Leukemia with Isochromosome (12p) after a Primary Mediastinal Germ Cell Tumor in Korea.
Nae YU ; Hye Ryoun KIM ; Young Joo CHA ; Eun Kyung PARK ; Jeong Wook KIM
Journal of Korean Medical Science 2011;26(8):1099-1102
The association of hematological malignancies with a mediastinal germ cell tumor (GCT) is very rare. We report one case of a young adult male with primary mediastinal GCT who subsequently developed acute megakaryoblastic leukemia involving isochromosome (12p). A 25-yr-old man had been diagnosed with a mediastinal GCT and underwent surgical resection and adjuvant chemotherapy. At 1 week after the last cycle of chemotherapy, his peripheral blood showed leukocytosis with blasts. A bone marrow study confirmed the acute megakaryoblastic leukemia. A cytogenetic study revealed a complex karyotype with i(12p). Although additional chemotherapy was administered, the patient could not attain remission and died of septic shock. This case was definitely distinct from therapy-related secondary leukemia in terms of clinical, morphologic, and cytogenetic features. To our knowledge, this is the first case report of a patient with mediastinal GCT subsequently developing acute megakaryoblastic leukemia involving i(12p) in Korea.
Adult
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Bleomycin/administration & dosage
;
Bone Marrow/pathology
;
*Chromosomes, Human, Pair 12
;
Cisplatin/administration & dosage
;
Etoposide/administration & dosage
;
Humans
;
Isochromosomes
;
Karyotyping
;
Leukemia, Megakaryoblastic, Acute/drug therapy/etiology/*genetics
;
Male
;
Mediastinal Neoplasms/*diagnosis/drug therapy/surgery
;
Neoplasms, Germ Cell and Embryonal/*diagnosis/drug therapy/surgery
;
Neoplasms, Second Primary/drug therapy/etiology/*genetics
;
Republic of Korea
;
Shock, Septic/pathology
6.Clinical features and prognosis in 104 colorectal cancer patients with bone metastases.
Ruo-xi HONG ; Qiu-ju LIN ; Jian LUO ; Zhen DAI ; Wen-na WANG
Chinese Journal of Oncology 2013;35(10):787-791
OBJECTIVETo investigate the clinical features and prognosis of bone metastases in colorectal cancer patients.
METHODSThe clinical data of 104 cases of colorectal cancer with bone metastasis were collected and retrospectively analyzed.
RESULTSAmong all the 104 patients included, 45 (43.3%) patients had multiple bone metastases, and 59 (56.7%) patients had single bone metastasis. Pelvis (46.1%) was the most common site, followed by thoracic vertebrae (41.3%), lumbar vertebrae (40.4%), sacral vertebrae (29.8%) and ribs (29.8%). One hundred and two patients (98.1%) were complicated with other organ metastases. The median time from colorectal cancer diagnosis to bone metastasis was 16 months, and the median time from bone metastasis to first skeletal-related events (SREs) was 1 month. The most common skeletal-related events (SREs) were the need for radiotherapy (44.2%), severe bone pain (15.4%) and pathologic fracture (9.6%). The median survival time of patients with bone metastases was 10.0 months, and 8.5 months for patients with SREs. ECOG score, systemic chemotherapy and bisphosphonate therapy were prognostic factors by univariate analysis (all P < 0.05). ECOG score and systemic chemotherapy were independent prognostic factors by Cox multivariate analysis.
CONCLUSIONSBone metastasis in colorectal cancer patients has a poor prognosis and the use of chemotherapy and bisphosphonates may have a benefit for their survival.
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Bone Density Conservation Agents ; therapeutic use ; Bone Neoplasms ; drug therapy ; radiotherapy ; secondary ; Colorectal Neoplasms ; drug therapy ; pathology ; radiotherapy ; surgery ; Diphosphonates ; therapeutic use ; Female ; Follow-Up Studies ; Fractures, Bone ; etiology ; Humans ; Lumbar Vertebrae ; pathology ; Male ; Middle Aged ; Pain ; etiology ; Pelvic Bones ; pathology ; Prognosis ; Retrospective Studies ; Ribs ; pathology ; Sacrum ; pathology ; Spinal Cord Compression ; etiology ; Spinal Neoplasms ; drug therapy ; radiotherapy ; secondary ; Thoracic Vertebrae ; pathology ; Young Adult
7.Acquired Amegakaryocytic Thrombocytopenia after Thymectomy in a Case of Pure Red Cell Aplasia Associated with Thymoma.
Ah Ra CHO ; Young Joo CHA ; Hye Ryoun KIM ; Eun Kyung PARK ; Eun Jong CHA
The Korean Journal of Laboratory Medicine 2010;30(3):244-248
The association of thymoma with pure red cell aplasia has been well documented, but amegakaryocytic thrombocytopenia is not a recognized paraneoplastic syndrome complicating thymoma. We report a case of thymoma-complicated pure red cell aplasia and amegakaryocytic thrombocytopenia in a 73-yr-old woman. Pure red cell aplasia was diagnosed seven months after the detection of thymoma. One year after the diagnosis of pure red cell aplasia and seven months after thymectomy, bone marrow aspiration and biopsy showed an absence of megakaryocytes, marked erythroid hypoplasia with normal myeloid series. A diagnosis of amegakaryocytic thrombocytopenia and pure red cell aplasia was made. Oral steroid maintenance therapy resulted in recovery of platelet count. She has still transfusion-dependant anemia but platelet and neutrophil counts had been maintained in normal range for more than five months, until the last follow-up. We think that autoreactive T cells may induce a clinical autoimmune response even after eradication of thymoma, and aplastic anemia as a late complication following thymectomy was described in previous cases. This patient also has to be under a close observation because of the possibility to evolve into aplastic anemia.
Aged
;
Bone Marrow/pathology
;
Female
;
Humans
;
Imidazoles/therapeutic use
;
Megakaryocytes/pathology
;
Pregnadienetriols/therapeutic use
;
Red-Cell Aplasia, Pure/complications/*diagnosis
;
Thrombocytopenia/*diagnosis/drug therapy/*etiology
;
Thymectomy/*adverse effects
;
Thymoma/*complications/diagnosis/surgery
;
Thymus Neoplasms/*complications/diagnosis/surgery
8.Factors related to biologic behavior in giant cell tumor of bone.
Xiang-ying RAN ; Jin HUANG ; Hui-zhen ZHANG ; Zhi-ming JIANG ; Jie CHEN
Chinese Journal of Pathology 2013;42(10):669-674
OBJECTIVETo study the histogenesis of giant cell tumor (GCT) and factors related to tumor recurrence, invasiveness and malignant transformation.
METHODSThe clinical features, radiologic classification, surgical approach, pathologic findings, immunophenotypes and follow-up data of 123 cases of GCT were analyzed.
RESULTSThere was a significant correlation between tumor recurrence and radiographic classification (P = 0.032), over-expression of CD147 (P = 0.034) and p53 (P = 0.005), and surgical approach (P = 0.0048) in GCT. The biologic behavior showed no correlation with intramedullary infiltration, cortical bone involvement, parosteal soft tissue extension, tumor thrombi, fusiform changes of mononuclear tumor cells, mitotic count, Ki-67 index, coagulative tumor necrosis, secondary aneurysmal bone cyst formation, and adjoining bony reaction. The positive rate of p63 in stromal cells of GCT (79.7%, 94/118) was significantly higher than that in chondroblastoma (44.7%, 21/47), osteosarcoma (22.2%, 10/45) and other giant cell-rich tumors.
CONCLUSIONSGCT is a bone tumor of low malignant potential. It is sometimes characterized by locally invasive growth, active proliferation, coagulative necrosis, secondary aneurysmal bone cyst and surrounding bony reaction. It is difficult to predict the biologic behavior of GCT. Over-expression of p53 in the tumor cells and CD147 in all components of GCT correlate with tumor invasiveness, recurrence and malignant transformation. Selection of suitable surgical approach with reference to radiologic classification is considered as an important factor in reducing the recurrence rate.
Adolescent ; Adult ; Aged ; Basigin ; metabolism ; Bone Neoplasms ; diagnostic imaging ; drug therapy ; metabolism ; pathology ; surgery ; Chemotherapy, Adjuvant ; Female ; Follow-Up Studies ; Giant Cell Tumor of Bone ; diagnostic imaging ; drug therapy ; metabolism ; pathology ; surgery ; Humans ; Male ; Membrane Proteins ; metabolism ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Osteosarcoma ; pathology ; Phosphoglucomutase ; metabolism ; Radiography ; Tumor Suppressor Protein p53 ; metabolism ; Young Adult
9.Primary Rectal Malignant Melanoma with Rapid Progression after Complete Resection.
Kyeong Ok KIM ; Byung Ik JANG ; Jae Hwang KIM ; Young Kyung BAE
The Korean Journal of Gastroenterology 2010;55(3):151-153
No abstract available.
Antigens, Neoplasm/metabolism
;
Bone Neoplasms/diagnosis/drug therapy/secondary
;
Disease Progression
;
Humans
;
Interferons/therapeutic use
;
Liver Neoplasms/diagnosis/drug therapy/secondary
;
Male
;
Melanoma/*diagnosis/pathology/surgery
;
Middle Aged
;
Neoplasm Proteins/metabolism
;
Positron-Emission Tomography
;
Rectal Neoplasms/*diagnosis/pathology/surgery
;
S100 Proteins/metabolism
;
Tamoxifen/therapeutic use
;
Tomography, X-Ray Computed
10.Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis.
Ming-Yuan CHEN ; ; Rou JIANG ; Ling GUO ; Xiong ZOU ; Qing LIU ; Rui SUN ; Fang QIU ; Zhong-Jun XIA ; Hui-Qiang HUANG ; Li ZHANG ; Ming-Huang HONG ; Hai-Qiang MAI ; Chao-Nan QIAN
Chinese Journal of Cancer 2013;32(11):604-613
Systemic chemotherapy is the basic palliative treatment for metastatic nasopharyngeal carcinoma (NPC); however, it is not known whether locoregional radiotherapy targeting the primary tumor and regional lymph nodes affects the survival of patients with metastatic NPC. Therefore, we aimed to retrospectively evaluate the benefits of locoregional radiotherapy. A total of 408 patients with metastatic NPC were included in this study. The mortality risks of the patients undergoing supportive treatment and those undergoing chemotherapy were compared with that of patients undergoing locoregional radiotherapy delivered alone or in combination with chemotherapy. Univariate and multivariate analyses were conducted. The contributions of independent factors were assessed after adjustment for covariates with significant prognostic associations (P < 0.05). Both locoregional radiotherapy and systemic chemotherapy were identified as significant independent prognostic factors of overall survival (OS). The mortality risk was similar in the group undergoing locoregional radiotherapy alone and the group undergoing systemic chemotherapy alone [multi-adjusted hazard ratio (HR) = 0.9, P = 0.529]; this risk was 60% lower than that of the group undergoing supportive treatment (HR = 0.4, P = 0.004) and 130% higher than that of the group undergoing both systemic chemotherapy and locoregional radiotherapy (HR = 2.3, P < 0.001). In conclusion, locoregional radiotherapy, particularly when combined with systemic chemotherapy, is associated with improved survival of patients with metastatic NPC.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Bone Neoplasms
;
drug therapy
;
radiotherapy
;
secondary
;
surgery
;
Chemoradiotherapy
;
Chemotherapy, Adjuvant
;
Cisplatin
;
administration & dosage
;
Deoxycytidine
;
administration & dosage
;
analogs & derivatives
;
Female
;
Follow-Up Studies
;
Humans
;
Liver Neoplasms
;
drug therapy
;
radiotherapy
;
secondary
;
surgery
;
Lung Neoplasms
;
drug therapy
;
radiotherapy
;
secondary
;
surgery
;
Male
;
Middle Aged
;
Nasopharyngeal Neoplasms
;
drug therapy
;
pathology
;
radiotherapy
;
Neoplasm Staging
;
Paclitaxel
;
administration & dosage
;
Palliative Care
;
Radiotherapy, Intensity-Modulated
;
Retrospective Studies
;
Survival Rate
;
Young Adult